BioRestorative Therapies (BRTX) to Release Quarterly Earnings on Thursday

BioRestorative Therapies (NASDAQ:BRTX) is expected to announce its earnings results on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.34) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies Stock Up 3.6 %

NASDAQ:BRTX opened at $1.71 on Friday. The company has a market cap of $11.83 million, a P/E ratio of -1.12 and a beta of 64.37. BioRestorative Therapies has a twelve month low of $1.03 and a twelve month high of $2.55. The business has a 50 day moving average price of $1.97 and a two-hundred day moving average price of $1.71.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.